Microsoft's premature release of GPT-4 test in India contributed to Sam Altman's ouster from OpenAI: WSJ report

Full Article
Microsoft's premature release of GPT-4 test in India contributed to Sam Altman's ouster from OpenAI: WSJ report

In November 2023, Sam Altman was removed as CEO of OpenAI due to a lack of transparency, particularly regarding the premature release of GPT-4 by Microsoft in India. This incident raised significant concerns about internal governance and communication within OpenAI, as the board was not informed about the release. Following a tumultuous period, Altman was reinstated after employee protests and support from key investors.

The release of GPT-4 without proper oversight highlighted serious issues within OpenAI's management structure. Altman's return was marked by gratitude towards employees and investors, including Microsoft’s Satya Nadella, who played a crucial role in the situation. The incident also revealed ongoing challenges within OpenAI, such as fund mismanagement and lack of communication about significant product launches.

• Microsoft released GPT-4 in India without OpenAI's approval.

• Sam Altman's ouster was linked to internal conflicts and fund mismanagement.

Key AI Terms Mentioned in this Article

GPT-4

GPT-4 is an advanced AI language model that was prematurely released, causing governance issues.

OpenAI Startup Fund

The fund was intended to invest in AI startups but faced criticism for profit-sharing practices.

AI Governance

AI governance refers to the frameworks and policies guiding the ethical use of AI technologies.

Companies Mentioned in this Article

Microsoft

Microsoft is a major investor in OpenAI and was involved in the controversial release of GPT-4.

OpenAI

OpenAI is a leading AI research organization that faced internal turmoil following Altman's ouster.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 4month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 4month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 4month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 4month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics